US Patent Issued to Imusyn on Sept. 1 for "Stabilized MHC I" (German Inventor)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,068, issued on Sept. 1, was assigned to Imusyn GmbH & Co. KG (Hannover, Germany).

"Stabilized MHC I" was invented by Clemens Schneeweiss (Hannover, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Modified MHC I molecules that can be expressed in cell culture and can be more stable than natural MHC I molecules. An analytical process uses the modified MHC I molecules, e.g. for determination of antibodies in a serum sample directed against these MHC I molecules. MHC I is provided which has at least one covalent bond formed between a Cystein in the alpha chain and a Cystein in the Beta2-microglobulin."

The patent was filed on April 2, 2020, unde...